There are no shortcuts when it comes to MACRA.
Successful payment reform in oncology requires a balanced approach. CMS’s proposed rules for Part B drugs amount to a superficial solution.
Bundling emergent procedures is a markedly different exercise than bundling elective procedures.
Hospital planning executives are understandably fuming about the restrictive and complicated rules.
Increased government investigations into fair market value and commercial reasonableness have significant implications for cardiologist compensation.
The 5-year pilot will have twice as many participants as initially anticipated.
A look back at the 2016 National Bundled Payment Summit in Washington, D.C.
Hospital administrators trying to determine which metrics to track for CJR need to keep things simple.
Under MACRA, CMS will place providers in the APM or MIPS track depending on activity in 2017.
Page 3 of 6